ZA200107906B - Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor. - Google Patents

Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor.

Info

Publication number
ZA200107906B
ZA200107906B ZA200107906A ZA200107906A ZA200107906B ZA 200107906 B ZA200107906 B ZA 200107906B ZA 200107906 A ZA200107906 A ZA 200107906A ZA 200107906 A ZA200107906 A ZA 200107906A ZA 200107906 B ZA200107906 B ZA 200107906B
Authority
ZA
South Africa
Prior art keywords
immunoglobuline
inhibit
binding
high affinity
affinity receptor
Prior art date
Application number
ZA200107906A
Other languages
English (en)
Inventor
Franz Kricek
Beda Stadler
Monique Vogel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200107906B publication Critical patent/ZA200107906B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200107906A 1999-04-14 2001-09-26 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor. ZA200107906B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds

Publications (1)

Publication Number Publication Date
ZA200107906B true ZA200107906B (en) 2003-08-27

Family

ID=10851525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107906A ZA200107906B (en) 1999-04-14 2001-09-26 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor.

Country Status (29)

Country Link
US (1) US7041288B2 (cs)
EP (1) EP1169353B1 (cs)
JP (1) JP4109829B2 (cs)
KR (1) KR100492202B1 (cs)
CN (1) CN1268644C (cs)
AR (1) AR029624A1 (cs)
AT (1) ATE392437T1 (cs)
AU (1) AU767712B2 (cs)
BR (1) BR0009781A (cs)
CA (1) CA2363991C (cs)
CO (1) CO5241329A1 (cs)
CZ (1) CZ20013673A3 (cs)
DE (1) DE60038608T2 (cs)
ES (1) ES2302693T3 (cs)
GB (1) GB9908533D0 (cs)
HK (1) HK1044544B (cs)
HU (1) HUP0200713A2 (cs)
IL (2) IL145507A0 (cs)
MX (1) MXPA01010348A (cs)
MY (1) MY141459A (cs)
NO (1) NO20014936L (cs)
PE (1) PE20010046A1 (cs)
PL (1) PL350676A1 (cs)
PT (1) PT1169353E (cs)
RU (1) RU2253655C2 (cs)
SK (1) SK14592001A3 (cs)
TR (1) TR200102877T2 (cs)
WO (1) WO2000063252A1 (cs)
ZA (1) ZA200107906B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
SE0101093D0 (sv) 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
WO2003015716A2 (en) 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
AR040778A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina).
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
UA95329C2 (ru) * 2006-12-14 2011-07-25 Шеринг-Плау Лтд. Собачий тимусный стромальный лимфопоэтин и его применение
PE20161560A1 (es) 2009-09-03 2017-01-11 Pfizer Vaccines Llc Vacuna de pcsk9
US8709424B2 (en) 2009-09-03 2014-04-29 Merck Sharp & Dohme Corp. Anti-GITR antibodies
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
WO2020176549A1 (en) * 2019-02-26 2020-09-03 Sorrento Therapeutics, Inc. Antigen binding proteins that bind bcma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0141783B2 (en) 1983-11-07 1993-06-16 The Wistar Institute Immune response to tumours and viruses induced by anti-idiotype antibodies
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
EP0407392B2 (en) * 1987-12-31 1998-10-28 Tanox Biosystems, Inc. UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
AU645783B2 (en) 1990-01-23 1994-01-27 Tanox Biosystems, Inc. Extracellular segments of human epsilon immunoglobulin anchoring peptides and antibodies specific therefor
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
CA2145757A1 (en) 1992-09-30 1994-04-14 Dennis R. Burton Human neutralizing monoclonal antibodies to human immunodeficiency virus
KR100498198B1 (ko) * 1996-03-01 2005-09-09 노파르티스 아게 알레르기에 대한 백신접종 및 치료를 위한 펩티드 임뮤노겐
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
CA2350163A1 (en) 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)

Also Published As

Publication number Publication date
IL145507A (en) 2008-11-03
HK1044544B (zh) 2008-11-21
NO20014936L (no) 2001-12-03
CN1268644C (zh) 2006-08-09
ATE392437T1 (de) 2008-05-15
PE20010046A1 (es) 2001-02-23
AU3966000A (en) 2000-11-02
WO2000063252A1 (en) 2000-10-26
NO20014936D0 (no) 2001-10-10
MXPA01010348A (es) 2002-10-23
SK14592001A3 (sk) 2002-05-09
DE60038608D1 (de) 2008-05-29
EP1169353B1 (en) 2008-04-16
CZ20013673A3 (cs) 2002-05-15
KR100492202B1 (ko) 2005-06-03
DE60038608T2 (de) 2009-06-10
JP4109829B2 (ja) 2008-07-02
CO5241329A1 (es) 2003-01-31
RU2253655C2 (ru) 2005-06-10
EP1169353A1 (en) 2002-01-09
GB9908533D0 (en) 1999-06-09
TR200102877T2 (tr) 2002-01-21
MY141459A (en) 2010-04-30
HK1044544A1 (en) 2002-10-25
CA2363991C (en) 2010-06-08
ES2302693T3 (es) 2008-08-01
KR20020007366A (ko) 2002-01-26
IL145507A0 (en) 2002-06-30
PL350676A1 (en) 2003-01-27
PT1169353E (pt) 2008-07-14
HUP0200713A2 (en) 2002-07-29
US20020141989A1 (en) 2002-10-03
US7041288B2 (en) 2006-05-09
JP2002544125A (ja) 2002-12-24
AU767712B2 (en) 2003-11-20
BR0009781A (pt) 2002-01-08
AR029624A1 (es) 2003-07-10
CN1346372A (zh) 2002-04-24
CA2363991A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
IL175399A (en) Antibodies binding to ob receptor variants
ZA200107906B (en) Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor.
EP1169352A4 (en) ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
EP1572874A3 (en) Antibodies that immunospecifically bind to trail receptors
EP1465925A4 (en) "ANTIBODIES THAT IMMUNE SPECIFICALLY TO TRAIL RECEPTORS"
HK1075470A1 (en) Antibodies that immunospecifically bind to trail receptors
IL144136A0 (en) Triazole compounds with dopamine-d3-receptor affinity
HK1086598A1 (en) Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
GB9911569D0 (en) Antibodies
EP1218413A4 (en) IRREVERSIBLE BINDING ANTIBODY MANIPULATIONS
IL148266A0 (en) Apo-2 receptor antibodies
AU2001297702A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2002352676A1 (en) Antibodies that immunospecifically bind to trail receptors
AU7099900A (en) Peptides that bind to urokinase receptor
ZA985101B (en) Peptides and compounds that bind to the IL-5 receptor.
GB9928195D0 (en) Over-flow saftey system
EP1278538A4 (en) ANTIBODIES BINDING TO CD18 AND INHIBITING STENOSE-RELATED DISORDERS
GB9921178D0 (en) Binder compositions
EP1278699A4 (en) PEPTIDES AND COMPOUNDS THAT MOUNT ON THE IL-5 RECEPTOR
TW389293U (en) Improved structure of binding ring
IL126245A0 (en) Antibodies to ifn-beta2/il-6 receptor
GB0212763D0 (en) Antibodies
GB9918051D0 (en) Antibodies
TW375900U (en) Structure of the hair binding chain
TW375009U (en) Improved structure for the connecting of the shaft